Industry News
Market report: Jitters return following poor U.S economic data
Australian shares slumped to a fortnightly low on Friday, weighed down by concerns about the U.S and Europe as well as uncertainty surrounding the proposed resources super profits tax (RSPT). [ + ]
ImpediMed clears final U.S hurdle for biompedance product
Brisbane biotech ImpediMed announced today that it has received a Category III coding from the American Medical Association ( AMA ) for the use of its L-Dex U400 bioimpedance spectroscopy ( BIS ) technology in the detection of lymphoedema in limbs, which will take effect on January 1 next year. [ + ]
Human Genome Project, 10 years on
10 years ago, on June 26, 2000, the first draft of the human genome was announced to the public with great ceremony and aplomb. And hyperbole. [ + ]
Revolutionary new Alzheimer’s test awaits FDA approval
A U.S company is nearing approval for a new scanning and dye procedure which could revolutionise the diagnosis and treatment of Alzheimer’s. [ + ]
First cannabis-based drug approved in Europe
The first cannabis-based pharmaceutical product has been approved in the UK, paving the way for widespread adoption throughout Europe. [ + ]
Major new African gene study announced
An ambitious new health project announced this week will seek to capitalise on Africa’s unique genetic diversity in a bid to further understanding of how genes interact with the environment in relation to diseases such as cancer, heart disease and malaria. [ + ]
Melanoma cases to double over next decade
The number of melanoma cases will double over the next 10 years, presenting attractive opportunities for drug companies to improve on existing poor and outdated standards of treatment. [ + ]
Melanoma cases to double over next decade
The number of cases of melanoma will double over the next 10 years, presenting attractive opportunities for drug companies to improve on existing poor and outdated standards of treatment. [ + ]
Green chemistry award for Dow and BASF’s HPPO technology
Dow Chemical and BASF have received a green chemistry award for their jointly developed hydrogen peroxide to propylene oxide (HPPO) technology.
[ + ]Research committee named for SAHMRI
A who’s who of Australian scientists have been tapped to direct the research of the new South Australian Health and Medical Research Institute (SAHMRI) in Adelaide. [ + ]
Swine flu follow-up criticised as inadequate
A study by Hong Kong researchers has highlighted worrying gaps in the follow up to last year’s outbreak of H1N1 swine flu which it says are largely responsible for a fast-spreading outbreak amongst pigs in China. [ + ]
Many SNPs make up heritability
The Human Genome Project was supposed to shine a light on the phenomenon of heritability, illuminating how certain complex traits are passed down from parent to offspring. [ + ]
Qiagen expands partnership
Qiagen has entered into an agreement with the Dutch molecular diagnostic component supplier Genome Diagnostics, which covers the development and commercialisation of six new tests until 2011.
[ + ]Monash builds on a green chemistry future
The Green Chemical Futures facility will be developed at the Clayton campus of Monash University. The $72.8 million project will be co-funded by the university and the federal government.
[ + ]
